Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 54% of the investors opened trades with bullish expectations and 45% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $215,635 and 8, calls, for a total amount of $404,905.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $410.0 to $650.0 for Eli Lilly over the recent three months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $410.0 to $650.0 in the last 30 days.
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BULLISH | 06/21/24 | $410.00 | $131.6K | 35 | 10 |
| LLY | PUT | SWEEP | BEARISH | 03/15/24 | $560.00 | $117.5K | 113 | 0 |
| LLY | PUT | SWEEP | BEARISH | 01/12/24 | $570.00 | $54.5K | 120 | 81 |
| LLY | CALL | TRADE | BULLISH | 02/16/24 | $570.00 | $48.0K | 488 | 12 |
| LLY | PUT | TRADE | BULLISH | 02/16/24 | $600.00 | $43.6K | 540 | 12 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Eli Lilly Standing Right Now?
- Trading volume stands at 159,187, with LLY's price up by 0.2%, positioned at $582.0.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 39 days.
Expert Opinions on Eli Lilly
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $610.0.
- In a cautious move, an analyst from Daiwa Capital downgraded its rating to Outperform, setting a price target of $610.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from Benzinga Pro.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
